Long-term enhancement of REM sleep by the pituitary adenylyl cyclase-activating polypeptide (PACAP) in the pontine reticular formation of the rat

Ahnaou, A. ; Basille, M. ; Gonzalez, B. ; Vaudry, H. ; Hamon, M. ; Adrien, J. ; Bourgin, P.

Oxford, UK : Blackwell Science Ltd
Published 1999
ISSN:
1460-9568
Source:
Blackwell Publishing Journal Backfiles 1879-2005
Topics:
Medicine
Notes:
In rats, rapid eye movement (REM) sleep can be elicited by microinjection of vasoactive intestinal polypeptide (VIP) into the oral pontine reticular nucleus (PnO). In the present study, we investigated whether this area could also be a REM-promoting target for a peptide closely related to VIP: the pituitary adenylyl cyclase-activating polypeptide (PACAP). When administered into the posterior part of the PnO, but not in nearby areas, of freely moving chronically implanted rats, PACAP-27 and PACAP-38 (0.3 and 3 pmol) induced a marked enhancement (60–85% over baseline) of REM sleep for 8 h that could be prevented by prior infusion of the antagonist PACAP-(6–27) (3 pmol) into the same site. Moreover, injections of PACAP into the centre of the posterior PnO resulted in REM sleep enhancement which could last for up to 11 consecutive days. Quantitative autoradiography using [125I]PACAP-27 revealed the presence in the PnO of specific binding sites with high affinity for PACAP-27 and PACAP-38 (IC50 = 2.4 and 3.2 nm, respectively), but very low affinity for VIP (IC50 〉 1 μm). These data suggest that PACAP within the PnO may play a key role in REM sleep regulation, and provide evidence for long-term (several days) mechanisms involved in such a control. PAC1 receptors which have a much higher affinity for PACAP than for VIP might mediate this long-term action of PACAP on REM sleep.
Type of Medium:
Electronic Resource
URL:
_version_ 1798290159905538049
autor Ahnaou, A.
Basille, M.
Gonzalez, B.
Vaudry, H.
Hamon, M.
Adrien, J.
Bourgin, P.
autorsonst Vaudry, H.
Hamon, M.
Adrien, J.
Bourgin, P.
book_url http://dx.doi.org/10.1046/j.1460-9568.1999.00811.x
datenlieferant nat_lic_papers
hauptsatz hsatz_simple
identnr NLZ242446876
insertion_date 2012-04-27
issn 1460-9568
journal_name European journal of neuroscience
materialart 1
notes In rats, rapid eye movement (REM) sleep can be elicited by microinjection of vasoactive intestinal polypeptide (VIP) into the oral pontine reticular nucleus (PnO). In the present study, we investigated whether this area could also be a REM-promoting target for a peptide closely related to VIP: the pituitary adenylyl cyclase-activating polypeptide (PACAP). When administered into the posterior part of the PnO, but not in nearby areas, of freely moving chronically implanted rats, PACAP-27 and PACAP-38 (0.3 and 3 pmol) induced a marked enhancement (60–85% over baseline) of REM sleep for 8 h that could be prevented by prior infusion of the antagonist PACAP-(6–27) (3 pmol) into the same site. Moreover, injections of PACAP into the centre of the posterior PnO resulted in REM sleep enhancement which could last for up to 11 consecutive days. Quantitative autoradiography using [125I]PACAP-27 revealed the presence in the PnO of specific binding sites with high affinity for PACAP-27 and PACAP-38 (IC50 = 2.4 and 3.2 nm, respectively), but very low affinity for VIP (IC50 〉 1 μm). These data suggest that PACAP within the PnO may play a key role in REM sleep regulation, and provide evidence for long-term (several days) mechanisms involved in such a control. PAC1 receptors which have a much higher affinity for PACAP than for VIP might mediate this long-term action of PACAP on REM sleep.
package_name Blackwell Publishing
publikationsjahr_anzeige 1999
publikationsjahr_facette 1999
publikationsjahr_intervall 8004:1995-1999
publikationsjahr_sort 1999
publikationsort Oxford, UK
publisher Blackwell Science Ltd
reference 11 (1999), S. 0
search_space articles
shingle_author_1 Ahnaou, A.
Basille, M.
Gonzalez, B.
Vaudry, H.
Hamon, M.
Adrien, J.
Bourgin, P.
shingle_author_2 Ahnaou, A.
Basille, M.
Gonzalez, B.
Vaudry, H.
Hamon, M.
Adrien, J.
Bourgin, P.
shingle_author_3 Ahnaou, A.
Basille, M.
Gonzalez, B.
Vaudry, H.
Hamon, M.
Adrien, J.
Bourgin, P.
shingle_author_4 Ahnaou, A.
Basille, M.
Gonzalez, B.
Vaudry, H.
Hamon, M.
Adrien, J.
Bourgin, P.
shingle_catch_all_1 Ahnaou, A.
Basille, M.
Gonzalez, B.
Vaudry, H.
Hamon, M.
Adrien, J.
Bourgin, P.
Long-term enhancement of REM sleep by the pituitary adenylyl cyclase-activating polypeptide (PACAP) in the pontine reticular formation of the rat
Blackwell Science Ltd
In rats, rapid eye movement (REM) sleep can be elicited by microinjection of vasoactive intestinal polypeptide (VIP) into the oral pontine reticular nucleus (PnO). In the present study, we investigated whether this area could also be a REM-promoting target for a peptide closely related to VIP: the pituitary adenylyl cyclase-activating polypeptide (PACAP). When administered into the posterior part of the PnO, but not in nearby areas, of freely moving chronically implanted rats, PACAP-27 and PACAP-38 (0.3 and 3 pmol) induced a marked enhancement (60–85% over baseline) of REM sleep for 8 h that could be prevented by prior infusion of the antagonist PACAP-(6–27) (3 pmol) into the same site. Moreover, injections of PACAP into the centre of the posterior PnO resulted in REM sleep enhancement which could last for up to 11 consecutive days. Quantitative autoradiography using [125I]PACAP-27 revealed the presence in the PnO of specific binding sites with high affinity for PACAP-27 and PACAP-38 (IC50 = 2.4 and 3.2 nm, respectively), but very low affinity for VIP (IC50 〉 1 μm). These data suggest that PACAP within the PnO may play a key role in REM sleep regulation, and provide evidence for long-term (several days) mechanisms involved in such a control. PAC1 receptors which have a much higher affinity for PACAP than for VIP might mediate this long-term action of PACAP on REM sleep.
1460-9568
14609568
shingle_catch_all_2 Ahnaou, A.
Basille, M.
Gonzalez, B.
Vaudry, H.
Hamon, M.
Adrien, J.
Bourgin, P.
Long-term enhancement of REM sleep by the pituitary adenylyl cyclase-activating polypeptide (PACAP) in the pontine reticular formation of the rat
Blackwell Science Ltd
In rats, rapid eye movement (REM) sleep can be elicited by microinjection of vasoactive intestinal polypeptide (VIP) into the oral pontine reticular nucleus (PnO). In the present study, we investigated whether this area could also be a REM-promoting target for a peptide closely related to VIP: the pituitary adenylyl cyclase-activating polypeptide (PACAP). When administered into the posterior part of the PnO, but not in nearby areas, of freely moving chronically implanted rats, PACAP-27 and PACAP-38 (0.3 and 3 pmol) induced a marked enhancement (60–85% over baseline) of REM sleep for 8 h that could be prevented by prior infusion of the antagonist PACAP-(6–27) (3 pmol) into the same site. Moreover, injections of PACAP into the centre of the posterior PnO resulted in REM sleep enhancement which could last for up to 11 consecutive days. Quantitative autoradiography using [125I]PACAP-27 revealed the presence in the PnO of specific binding sites with high affinity for PACAP-27 and PACAP-38 (IC50 = 2.4 and 3.2 nm, respectively), but very low affinity for VIP (IC50 〉 1 μm). These data suggest that PACAP within the PnO may play a key role in REM sleep regulation, and provide evidence for long-term (several days) mechanisms involved in such a control. PAC1 receptors which have a much higher affinity for PACAP than for VIP might mediate this long-term action of PACAP on REM sleep.
1460-9568
14609568
shingle_catch_all_3 Ahnaou, A.
Basille, M.
Gonzalez, B.
Vaudry, H.
Hamon, M.
Adrien, J.
Bourgin, P.
Long-term enhancement of REM sleep by the pituitary adenylyl cyclase-activating polypeptide (PACAP) in the pontine reticular formation of the rat
Blackwell Science Ltd
In rats, rapid eye movement (REM) sleep can be elicited by microinjection of vasoactive intestinal polypeptide (VIP) into the oral pontine reticular nucleus (PnO). In the present study, we investigated whether this area could also be a REM-promoting target for a peptide closely related to VIP: the pituitary adenylyl cyclase-activating polypeptide (PACAP). When administered into the posterior part of the PnO, but not in nearby areas, of freely moving chronically implanted rats, PACAP-27 and PACAP-38 (0.3 and 3 pmol) induced a marked enhancement (60–85% over baseline) of REM sleep for 8 h that could be prevented by prior infusion of the antagonist PACAP-(6–27) (3 pmol) into the same site. Moreover, injections of PACAP into the centre of the posterior PnO resulted in REM sleep enhancement which could last for up to 11 consecutive days. Quantitative autoradiography using [125I]PACAP-27 revealed the presence in the PnO of specific binding sites with high affinity for PACAP-27 and PACAP-38 (IC50 = 2.4 and 3.2 nm, respectively), but very low affinity for VIP (IC50 〉 1 μm). These data suggest that PACAP within the PnO may play a key role in REM sleep regulation, and provide evidence for long-term (several days) mechanisms involved in such a control. PAC1 receptors which have a much higher affinity for PACAP than for VIP might mediate this long-term action of PACAP on REM sleep.
1460-9568
14609568
shingle_catch_all_4 Ahnaou, A.
Basille, M.
Gonzalez, B.
Vaudry, H.
Hamon, M.
Adrien, J.
Bourgin, P.
Long-term enhancement of REM sleep by the pituitary adenylyl cyclase-activating polypeptide (PACAP) in the pontine reticular formation of the rat
Blackwell Science Ltd
In rats, rapid eye movement (REM) sleep can be elicited by microinjection of vasoactive intestinal polypeptide (VIP) into the oral pontine reticular nucleus (PnO). In the present study, we investigated whether this area could also be a REM-promoting target for a peptide closely related to VIP: the pituitary adenylyl cyclase-activating polypeptide (PACAP). When administered into the posterior part of the PnO, but not in nearby areas, of freely moving chronically implanted rats, PACAP-27 and PACAP-38 (0.3 and 3 pmol) induced a marked enhancement (60–85% over baseline) of REM sleep for 8 h that could be prevented by prior infusion of the antagonist PACAP-(6–27) (3 pmol) into the same site. Moreover, injections of PACAP into the centre of the posterior PnO resulted in REM sleep enhancement which could last for up to 11 consecutive days. Quantitative autoradiography using [125I]PACAP-27 revealed the presence in the PnO of specific binding sites with high affinity for PACAP-27 and PACAP-38 (IC50 = 2.4 and 3.2 nm, respectively), but very low affinity for VIP (IC50 〉 1 μm). These data suggest that PACAP within the PnO may play a key role in REM sleep regulation, and provide evidence for long-term (several days) mechanisms involved in such a control. PAC1 receptors which have a much higher affinity for PACAP than for VIP might mediate this long-term action of PACAP on REM sleep.
1460-9568
14609568
shingle_title_1 Long-term enhancement of REM sleep by the pituitary adenylyl cyclase-activating polypeptide (PACAP) in the pontine reticular formation of the rat
shingle_title_2 Long-term enhancement of REM sleep by the pituitary adenylyl cyclase-activating polypeptide (PACAP) in the pontine reticular formation of the rat
shingle_title_3 Long-term enhancement of REM sleep by the pituitary adenylyl cyclase-activating polypeptide (PACAP) in the pontine reticular formation of the rat
shingle_title_4 Long-term enhancement of REM sleep by the pituitary adenylyl cyclase-activating polypeptide (PACAP) in the pontine reticular formation of the rat
sigel_instance_filter dkfz
geomar
wilbert
ipn
albert
source_archive Blackwell Publishing Journal Backfiles 1879-2005
timestamp 2024-05-06T08:12:17.930Z
titel Long-term enhancement of REM sleep by the pituitary adenylyl cyclase-activating polypeptide (PACAP) in the pontine reticular formation of the rat
titel_suche Long-term enhancement of REM sleep by the pituitary adenylyl cyclase-activating polypeptide (PACAP) in the pontine reticular formation of the rat
topic WW-YZ
uid nat_lic_papers_NLZ242446876